If you made any changes in Pure these will be visible here soon.

Personal profile

Personal profile

Dr. Michael J. Reardon is a native Houstonian who attended Baylor College of Medicine where he graduated with honors and as a member of AOA. He did his general surgery residency under Dr. Michael DeBakey and cardiothoracic residency under Dr. Denton Cooley. He joined the staff of the Houston Methodist Hospital in 1985 and ran a private practice until 1993. He then joined the full time faculty of BCM rising to Professor of Surgery with tenure, Chief of Cardiothoracic Surgery and Director of the thoracic residency program. He subsequently joined the academic group at the HMH as Professor of Cardiothoracic Surgery and Chief of Cardiac Surgery.

His interests have centered on aortic surgery, cardiac valve surgery and cardiac tumors. His recent research and clinical interests have focused on minimally invasive, catheter-based approaches to these areas. He serves on the national steering committee for the CoreValve, SurTAVI and reprise III TAVR trials and as national surgical PI on the SurTAVI trial, reprise III trial and the Gore type A dissection trial. Dr. Reardon also serves as the international surgical PI for the Reprise III trial.

He holds the position of Clinical Professor of Cardiothoracic Surgery at MD Anderson Cancer Center and created the multi-institution, multidisciplinary cardiac tumor team with HMH and MDA. He has operated on more primary cardiac sarcomas than any other surgeon globally and written extensively on this topic. Dr. Reardon's group recently published the largest series of surgically treated primary cardiac sarcomas in the world. Surgical Treatment of Primary Cardiac Sarcomas: Review of a Single-Institution Experience PMID 26476808

He has served as elected president of the medical staff for the HMH and received numerous awards including the Overstreet Award and Noon Award. He currently holds the Allison Family Distinguished Chair of Cardiovascular Research and divides his time between building innovative clinical, research and educational programs.

Research interests

He has been the principal and co-investigator on several industry and government-sponsored clinical trials and research initiatives, and he is currently on the national steering and screening committees for the Medtronic CoreValve US Pivotal Trial and the international steering committee for the SurTAVI Trial, for which he is also a national surgical principal investigator. His research interests include cardiac tumor treatment, catheter based approaches to structural heart disease, catheter based and open aortic disease treatment Having published more than 300 articles and abstracts, Dr. Reardon conducts peer reviews for publications such as the Annals of Thoracic Surgery and Circulation and is the associate editor of surgery for the Methodist DeBakey Cardiovascular Journal.

Education/Academic qualification

Certificate, Healthcare Management, Rice University

2005

Award Date: Jun 30 2005

Fellow, Harvard University Alley-Sheridan School of Government

1998

Award Date: Dec 31 1998

Cardiothoracic Surgery , Residency, Texas Heart Institute

19831985

Award Date: Jun 30 1985

General Surgery, Residency, Baylor College of Medicine

19781983

Award Date: Jun 30 1983

MD, Baylor College of Medicine

19751978

Award Date: Jun 30 1978

Research Area Keywords

  • Regenerative Medicine
  • Heart & Vascular
  • Clinical Translation & Trials

Free-text keywords

  • Cardiac tumor treatment
  • Catheter based approaches to structural heart disease
  • Catheter based and open aortic disease treatments
  • Cardiac valve disease
  • Aortic surgery
  • Cardiac tumor surgery
  • Complex cardiac surgery

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Research Output

Association Between Institutional Mitral Valve Procedure Volume and Mitral Valve Repair Outcomes in Medicare Patients

Barker, C. M., Reardon, M. J., Reynolds, M. R. & Feldman, T. E., May 11 2020, In : JACC: Cardiovascular Interventions. 13, 9, p. 1137-1139 3 p.

Research output: Contribution to journalLetter

Bioprosthetic Aortic Valve Leaflet Thickening in the Evolut Low Risk Sub-Study

Evolut Low Risk LTI Substudy Investigators, May 19 2020, In : Journal of the American College of Cardiology. 75, 19, p. 2430-2442 13 p.

Research output: Contribution to journalArticle

  • 1 Scopus citations

    Cardiac paragangliomas: A case series with clinicopathologic features and succinate dehydrogenase B immunostaining

    Alakeel, F., Al Sannaa, G., Ibarra-Cortez, S. H., Reardon, M. J., Czerniak, B., Chan, E. Y. & Ro, J., Apr 2020, In : Annals of Diagnostic Pathology. 45, 151477.

    Research output: Contribution to journalArticle

  • Commentary: To OAC or not to OAC? That is the question

    Atkins, M. & Reardon, M. J., May 2020, In : Journal of Thoracic and Cardiovascular Surgery. 159, 5, p. 1740-1741 2 p.

    Research output: Contribution to journalEditorial

    Commentary: Black swan theory or just another bird sighting?

    Lin, C. H. & Reardon, M. J., Aug 2020, In : Journal of Thoracic and Cardiovascular Surgery. 160, 2, p. 510-511 2 p.

    Research output: Contribution to journalEditorial